Lijuan Chen, Na Gao, Wei Yang, Qike Zhang, Hu Zhu, Zhihua Zhang, Lin Liu, Yong Wu, Jinxiao Yao, Zhenfang Liu, Zhenya Hong, Yanping Song, Xiaoyu Zhu, Jia Miao, Jinrong Yang, Ke Tan, Adrian Rui Liang, Zefeng Xu, Ting Niu, Zhijian Xiao. "Preliminary analysis of a phase 2b, randomized, active-control study of flonoltinib maleate (FM) vs. ruxolitinib in intermediate-2 or high-risk myelofibrosis patients." Blood (2025). https://doi.org/10.1182/blood-2025-908